Repertoire of BALB/c Mice Natural Anti-Carbohydrate Antibodies: Mice vs. Humans Difference, and Otherness of Individual Animals

One of the most common genetic backgrounds for mice used as a model to investigate human diseases is the inbred BALB/c strain. This work is aimed to characterize the pattern of natural anti-carbohydrate antibodies present in the serum of 20 BALB/c mice by printed glycan array technology and to compa...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 8; p. 1449
Main Authors Bello-Gil, Daniel, Khasbiullina, Nailya, Shilova, Nadezhda, Bovin, Nicolai, Mañez, Rafael
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 06.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:One of the most common genetic backgrounds for mice used as a model to investigate human diseases is the inbred BALB/c strain. This work is aimed to characterize the pattern of natural anti-carbohydrate antibodies present in the serum of 20 BALB/c mice by printed glycan array technology and to compare their binding specificities with that of human natural anti-carbohydrate antibodies. Natural antibodies (NAbs) from the serum of BALB/c mice interacted with 71 glycans from a library of 419 different carbohydrate structures. However, only seven of these glycans were recognized by the serum of all the animals studied, and other five glycans by at least 80% of mice. The pattern of the 12 glycans mostly recognized by the circulating antibodies of BALB/c mice differed significantly from that observed with natural anti-carbohydrate antibodies in humans. This lack of identical repertoires of natural anti-carbohydrate antibodies between individual inbred mice, and between mice and humans, should be taken into consideration when mouse models are intended to be used for investigation of NAbs in biomedical research.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Peter Isaac Lobo, University of Virginia, United States; Harry W. Schroeder, University of Alabama at Birmingham, United States
Edited by: Victoriano Mulero, Universidad de Murcia, Spain
Specialty section: This article was submitted to Comparative Immunology, a section of the journal Frontiers in Immunology
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2017.01449